Evidence map›Paper›PMID 37238422›Full record

ArticleChildren (Basel, Switzerland)2023

Incidental Hyperferritinemia in Very Young Infants with Mild Symptoms of COVID-19 Disease.

Yuka Shishido, Haruhiko Nakamura, Tomohiro Nakagawa, Shinsuke Kanou, Takeshi Ito, Shota Kuwana, Chiharu Ota

Open access · goldAbstract readCase Reports
In one paragraph

Article in Children (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yuka ShishidoDepartment of Pediatrics, Japanese Red Cross Ishinomaki Hospital, Ishinomaki 9868522, Japan.ORCID 0000-0003-2546-4023
Haruhiko NakamuraDepartment of Pediatrics, Japanese Red Cross Ishinomaki Hospital, Ishinomaki 9868522, Japan.ORCID 0000-0002-4236-799X
Tomohiro NakagawaDepartment of Pediatrics, Tohoku University Hospital, Sendai 9808574, Japan.
Shinsuke KanouDepartment of Pediatrics, Japanese Red Cross Ishinomaki Hospital, Ishinomaki 9868522, Japan.
Takeshi ItoDepartment of Pediatrics, Japanese Red Cross Ishinomaki Hospital, Ishinomaki 9868522, Japan.
Shota KuwanaDepartment of Pediatrics, Japanese Red Cross Ishinomaki Hospital, Ishinomaki 9868522, Japan.
Chiharu OtaDepartment of Pediatrics, Tohoku University Hospital, Sendai 9808574, Japan.ORCID 0000-0002-0644-1144
Miyagi Children's Hospital · JPTohoku University · JPTohoku University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe number of children infected with novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has increased during the outbreak of the Omicron strain. Hyperferritinemia has been reported in severe cases of COVID-19, and in children or neonates with multisystem inflammatory syndrome (MIS). Hyperferritinemia is considered to be one of the signs of MIS, but thus far, there have been few summarized reports on it. We retrospectively analyzed four infants less than 3 months of age with SARS-CoV-2 infections treated in our institution during the outbreak of the Omicron strain.

resultsmost patients were in good condition, but hyperferritinemia was observed in all of four cases.

conclusionsHyperferritinemia can be observed in infantile COVID-19 patients even with mild symptoms. It is necessary to carefully monitor their clinical course and monitor the patients.

Indexed as

early infantile COVID-19hyperferritinemiaJapanmultisystem inflammatory syndrome

Identifiers

PMID37238422
PMCPMC10217696
OpenAlexW4378516569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.